Despite its identification in 1997, the functions of the MEN1 gene—the main gene underlying
multiple endocrine neoplasia type 1 syndrome—are not yet fully understood. In addition …

Although anatomic imaging to assess the precise localization of pheochromocytomas/
paragangliomas (PHEOs/PGLs) is unavoidable before any surgical intervention on these …

Objective The aim of this study was to integrate European epidemiological data on patients
with multiple endocrine neoplasia type 1 by creating an Italian registry of this syndrome …

Background Pancreatic neuroendocrine tumors (pNETs) are highly prevalent in patients with
multiple endocrine neoplasia type 1 (MEN1), and metastatic disease is an important cause …

Multiple endocrine neoplasia (MEN) are clinical inherited syndromes affecting different
endocrine glands. Three different patterns of MEN syndromes can occur (MEN 1, MEN 2A …

Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited tumor
syndrome, associated with parathyroid, pituitary, and gastro-entero-pancreatic (GEP) …

Pituitary adenomas are a common feature of a subset of endocrine neoplasia syndromes,
which have otherwise highly variable disease manifestations. We provide here a review of …

Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited syndrome caused by
inactivating heterozygote mutations of the MEN1 gene affecting parathyroid glands …

Since the discovery of the multiple endocrine neoplasia type 1 (MEN1) gene in 1997,
elucidation of the molecular function of its protein product, menin, has been a challenge …

Context: Sixty to 80% of multiple endocrine neoplasia type 1 (MEN1) patients develop
pancreatic neuroendocrine neoplasias (pNENs), which reveal an aggressive behavior in …